We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
75 hedge funds and large institutions have $207M invested in MyoKardia, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
95% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 19
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
6% more capital invested
Capital invested by funds: $196M → $207M (+$11.3M)
3% more funds holding
Funds holding: 73 → 75 (+2)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
75
Holders Change
+2
Holders Change %
+2.74%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
37
Reduced
19
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$3.19M |
| 2 |
BlackRock
New York
|
+$2.71M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.08M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.77M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1.73M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.32M |
| 2 |
DM
Deerfield Management
New York
|
-$1.91M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.71M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.55M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.24M |
